English

CORBUS PHARMACEUTICALS HOLDINGS, INC.

EDGAR

CRBP Current report (8-K) · filed 2026-10-15

112 filing records in this dataset, filed from 2014-09-03 to 2026-10-15. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

0 USD

2022 Q4 · USD

Exact inputs and evidence

Revenue: 0 USD Source
Revenue: 0 USD Source

Operating cash flow

-7.45 million USD

2022 Q4 · USD

Exact inputs and evidence

Operating Cash Flow: -37544435 USD Source
Operating Cash Flow: -30089450 USD Source

Free cash flow

-7.45 million USD

2022 Q4 · USD

Exact inputs and evidence

Operating Cash Flow: -37544435 USD Source
Operating Cash Flow: -30089450 USD Source
Capital Expenditure: 13449 USD Source
Capital Expenditure: 13449 USD Source

Cash and cash equivalents: 23.4 million USD 2026-06-30 Source
Exact value

23370000 USD
Long-term debt including current maturities: 17.9 million USD 2023-12-31 Source
Exact value

17893738 USD
Shares outstanding: 18.7 million shares 2026-06-30 Source
Exact value

18671498 shares

Reported share-count change

52.37% · 6.42 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

12254069 shares · 2025-06-30· Source
18671498 shares · 2026-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

-102 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Net income: -23342000 USD · 2025-07-01 – 2025-09-30 Source
Net income: -78537000 USD · 2025-01-01 – 2025-12-31 Source
Net income: -57982000 USD · 2025-01-01 – 2025-09-30 Source
Net income: -22969000 USD · 2026-01-01 – 2026-03-31 Source
Net income: -35037000 USD · 2026-04-01 – 2026-06-30 Source

Operating cash flow

-86.7 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Operating cash flow: -48570000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -33020000 USD · 2025-01-01 – 2025-06-30 Source
Operating cash flow: -64491000 USD · 2025-01-01 – 2025-12-31 Source
Operating cash flow: -48570000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -25571000 USD · 2026-01-01 – 2026-03-31 Source
Operating cash flow: -55197000 USD · 2026-01-01 – 2026-06-30 Source
Operating cash flow: -25571000 USD · 2026-01-01 – 2026-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-10-15.

Financial data available through: 2025-12-31.

Coverage by financial measure

Revenue: 8 of 11 periods available· newest 2022-12-31
Operating income: 11 of 11 periods available· newest 2025-12-31
Net income: 11 of 11 periods available· newest 2025-12-31
Operating cash flow: 11 of 11 periods available· newest 2025-12-31
Capital expenditure: 11 of 11 periods available· newest 2025-12-31
Total assets: 11 of 11 periods available· newest 2025-12-31
Total liabilities: 11 of 11 periods available· newest 2025-12-31
Current assets: 11 of 11 periods available· newest 2025-12-31
Current liabilities: 11 of 11 periods available· newest 2025-12-31
Cash and cash equivalents: 11 of 11 periods available· newest 2025-12-31
Long-term debt including current maturities: 4 of 11 periods available· newest 2023-12-31
Shares outstanding: 11 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Net income
−USD 38.33 million

Prior period

−USD 40.21 million

2024-01-01 – 2024-12-31
Current period

−USD 78.54 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-78537000 − -40209000 = -38328000 USD

-40209000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-78537000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · CORBUS PHARMACEUTICALS HOLDINGS, INC. · 2025-12-31 CORBUS PHARMACEUTICALS HOLDINGS, INC. (edgar:1595097) Year-over-year change in Net income: -38328000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T19:45:32Z Snapshot: 36c1ffac13cc9fd73805c6c3dc334e9e5a5281335ba251ab1dfe4499f55c15f0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1595097?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -78537000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1595097/000119312526098530/crbp-20251231.htm#2887641 Filing: 000119312526098530 Input fundies:NetIncome: -40209000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1595097/000119312526098530/crbp-20251231.htm#2889498 Filing: 000119312526098530
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 22.7 million

Prior period

−USD 41.79 million

2024-01-01 – 2024-12-31
Current period

−USD 64.49 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-64491000 − -41794000 = -22697000 USD

-41794000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-64491000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · CORBUS PHARMACEUTICALS HOLDINGS, INC. · 2025-12-31 CORBUS PHARMACEUTICALS HOLDINGS, INC. (edgar:1595097) Year-over-year change in Operating cash flow: -22697000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T19:45:32Z Snapshot: 36c1ffac13cc9fd73805c6c3dc334e9e5a5281335ba251ab1dfe4499f55c15f0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1595097?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -64491000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1595097/000119312526098530/crbp-20251231.htm#2240341 Filing: 000119312526098530 Input fundies:OperatingCashFlow: -41794000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1595097/000119312526098530/crbp-20251231.htm#2242196 Filing: 000119312526098530
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+USD 7,000

Prior period

USD 0

2024-01-01 – 2024-12-31
Current period

USD 7,000

2025-01-01 – 2025-12-31

Exact inputs and evidence

7000 − 0 = 7000 USD

0 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
7000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · CORBUS PHARMACEUTICALS HOLDINGS, INC. · 2025-12-31 CORBUS PHARMACEUTICALS HOLDINGS, INC. (edgar:1595097) Year-over-year change in Capital expenditure: 7000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T19:45:32Z Snapshot: 36c1ffac13cc9fd73805c6c3dc334e9e5a5281335ba251ab1dfe4499f55c15f0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1595097?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 7000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1595097/000119312526098530/crbp-20251231.htm#2246907 Filing: 000119312526098530 Input fundies:CapitalExpenditure: 0 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1595097/000119312526098530/crbp-20251231.htm#2248546 Filing: 000119312526098530
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2022 2022-01-01 – 2022-12-31

Revenue USD 0
Operating costs Derived USD 39.84 million
Operating income −USD 39.84 million
Tax, interest and other Derived USD 2.51 million
Net income −USD 42.35 million

Cash

Operating cash flow −USD 37.54 million
Capital expenditure USD 13,449
Free cash flow Derived −USD 37.56 million

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2016 Operating loss: operating costs were 1,146% of revenue.
2017 Operating loss: operating costs were 1,434% of revenue.
2018 Operating loss: operating costs were 1,277% of revenue.
2019 Operating loss: operating costs were 313% of revenue.
2020 Operating loss: operating costs were 3,219% of revenue.
2021 Operating loss: operating costs were 6,450% of revenue.
2022 Not shown: operating income or net income is not reported.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2016 2016-01-01 – 2016-12-31	1911424	21896482 Derived	-19985058	13617 Derived	-19998675	-13924259 Derived	Source 2016-01-01 – 2016-12-31: 1911424 USD Inspect Revenue Open source 2016-01-01 – 2016-12-31: -19985058 USD Inspect Operating Income Open source 2016-01-01 – 2016-12-31: -19998675 USD Inspect Net Income Open source 2016-01-01 – 2016-12-31: -13571227 USD Inspect Operating Cash Flow Open source 2016-01-01 – 2016-12-31: 353032 USD Inspect Capital Expenditure Open source
2017 2017-01-01 – 2017-12-31	2440195	35003011 Derived	-32562816	-141204 Derived	-32421612	-28504057 Derived	Source 2017-01-01 – 2017-12-31: 2440195 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: -32562816 USD Inspect Operating Income Open source 2017-01-01 – 2017-12-31: -32421612 USD Inspect Net Income Open source 2017-01-01 – 2017-12-31: -27796628 USD Inspect Operating Cash Flow Open source 2017-01-01 – 2017-12-31: 707429 USD Inspect Capital Expenditure Open source
2018 2018-01-01 – 2018-12-31	4822272	61569979 Derived	-56747707	-1075568 Derived	-55672139	-32367671 Derived	Source 2018-01-01 – 2018-12-31: 4822272 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: -56747707 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: -55672139 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: -30067255 USD Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: 2300416 USD Inspect Capital Expenditure Open source
2019 2019-01-01 – 2019-12-31	36143568	113248147 Derived	-77104579	-5650861 Derived	-71453718	-48463269 Derived	Source 2019-01-01 – 2019-12-31: 36143568 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: -77104579 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: -71453718 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: -45720728 USD Inspect Operating Cash Flow Open source 2019-01-01 – 2019-12-31: 2742541 USD Inspect Capital Expenditure Open source
2020 2020-01-01 – 2020-12-31	3937230	126747463 Derived	-122810233	-11540853 Derived	-111269380	-100170194 Derived	Source 2020-01-01 – 2020-12-31: 3937230 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: -122810233 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -111269380 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: -99685703 USD Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 484491 USD Inspect Capital Expenditure Open source
2021 2021-01-01 – 2021-12-31	881705	56870729 Derived	-55989024	-10348598 Derived	-45640426	-48237869 Derived	Source 2021-01-01 – 2021-12-31: 881705 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: -55989024 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -45640426 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: -48183697 USD Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 54172 USD Inspect Capital Expenditure Open source
2022 2022-01-01 – 2022-12-31	0	39835445 Derived	-39835445	2511458 Derived	-42346903	-37557884 Derived	Source 2022-01-01 – 2022-12-31: 0 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: -39835445 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: -42346903 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: -37544435 USD Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 13449 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 0 2022

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20152015-12-31	Revenue	648382	Revenue: 648382 Open source
20162016-12-31	Revenue	1911424	Revenue: 1911424 Open source
20172017-12-31	Revenue	2440195	Revenue: 2440195 Open source
20182018-12-31	Revenue	4822272	Revenue: 4822272 Open source
20192019-12-31	Revenue	36143568	Revenue: 36143568 Open source
20202020-12-31	Revenue	3937230	Revenue: 3937230 Open source
20212021-12-31	Revenue	881705	Revenue: 881705 Open source
20222022-12-31	Revenue	0	Revenue: 0 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-100% 2022

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20152015-12-31	Year over year	No prior comparable period	Revenue: 648382 Open source
20162016-12-31	Year over year	194.8%	Revenue: 1911424 Open source Revenue: 648382 Open source
20172017-12-31	Year over year	27.7%	Revenue: 2440195 Open source Revenue: 1911424 Open source
20182018-12-31	Year over year	97.6%	Revenue: 4822272 Open source Revenue: 2440195 Open source
20192019-12-31	Year over year	649.5%	Revenue: 36143568 Open source Revenue: 4822272 Open source
20202020-12-31	Year over year	-89.1%	Revenue: 3937230 Open source Revenue: 36143568 Open source
20212021-12-31	Year over year	-77.6%	Revenue: 881705 Open source Revenue: 3937230 Open source
20222022-12-31	Year over year	-100%	Revenue: 0 Open source Revenue: 881705 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -6,350.1% 2021

Net margin -5,176.4% 2021

Free cash flow margin -5,471% 2021

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20152015-12-31	Operating margin	-1,365.5%	Operating Income: -8853693 Open source Revenue: 648382 Open source
20162016-12-31	Operating margin	-1,045.6%	Operating Income: -19985058 Open source Revenue: 1911424 Open source
20172017-12-31	Operating margin	-1,334.4%	Operating Income: -32562816 Open source Revenue: 2440195 Open source
20182018-12-31	Operating margin	-1,176.8%	Operating Income: -56747707 Open source Revenue: 4822272 Open source
20192019-12-31	Operating margin	-213.3%	Operating Income: -77104579 Open source Revenue: 36143568 Open source
20202020-12-31	Operating margin	-3,119.2%	Operating Income: -122810233 Open source Revenue: 3937230 Open source
20212021-12-31	Operating margin	-6,350.1%	Operating Income: -55989024 Open source Revenue: 881705 Open source
20222022-12-31	Operating margin	Not reported	Operating Income: -39835445 Open source Revenue: 0 Open source
20152015-12-31	Net margin	-1,365.1%	Net Income: -8850739 Open source Revenue: 648382 Open source
20162016-12-31	Net margin	-1,046.3%	Net Income: -19998675 Open source Revenue: 1911424 Open source
20172017-12-31	Net margin	-1,328.6%	Net Income: -32421612 Open source Revenue: 2440195 Open source
20182018-12-31	Net margin	-1,154.5%	Net Income: -55672139 Open source Revenue: 4822272 Open source
20192019-12-31	Net margin	-197.7%	Net Income: -71453718 Open source Revenue: 36143568 Open source
20202020-12-31	Net margin	-2,826.1%	Net Income: -111269380 Open source Revenue: 3937230 Open source
20212021-12-31	Net margin	-5,176.4%	Net Income: -45640426 Open source Revenue: 881705 Open source
20222022-12-31	Net margin	Not reported	Net Income: -42346903 Open source Revenue: 0 Open source
20152015-12-31	Free cash flow margin	Not reported	Revenue: 648382 Open source
20162016-12-31	Free cash flow margin	-728.5%	Revenue: 1911424 Open source Operating Cash Flow: -13571227 Open source Capital Expenditure: 353032 Open source
20172017-12-31	Free cash flow margin	-1,168.1%	Revenue: 2440195 Open source Operating Cash Flow: -27796628 Open source Capital Expenditure: 707429 Open source
20182018-12-31	Free cash flow margin	-671.2%	Revenue: 4822272 Open source Operating Cash Flow: -30067255 Open source Capital Expenditure: 2300416 Open source
20192019-12-31	Free cash flow margin	-134.1%	Revenue: 36143568 Open source Operating Cash Flow: -45720728 Open source Capital Expenditure: 2742541 Open source
20202020-12-31	Free cash flow margin	-2,544.2%	Revenue: 3937230 Open source Operating Cash Flow: -99685703 Open source Capital Expenditure: 484491 Open source
20212021-12-31	Free cash flow margin	-5,471%	Revenue: 881705 Open source Operating Cash Flow: -48183697 Open source Capital Expenditure: 54172 Open source
20222022-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -37544435 Open source Capital Expenditure: 13449 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -37.5M 2022

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20152015-12-31	Operating cash flow	Not reported	No source recorded
20162016-12-31	Operating cash flow	-13571227	Operating Cash Flow: -13571227 Open source
20172017-12-31	Operating cash flow	-27796628	Operating Cash Flow: -27796628 Open source
20182018-12-31	Operating cash flow	-30067255	Operating Cash Flow: -30067255 Open source
20192019-12-31	Operating cash flow	-45720728	Operating Cash Flow: -45720728 Open source
20202020-12-31	Operating cash flow	-99685703	Operating Cash Flow: -99685703 Open source
20212021-12-31	Operating cash flow	-48183697	Operating Cash Flow: -48183697 Open source
20222022-12-31	Operating cash flow	-37544435	Operating Cash Flow: -37544435 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -37.6M 2022

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20152015-12-31	Free cash flow	Unavailable	No source recorded
20162016-12-31	Free cash flow	-13924259	Operating Cash Flow: -13571227 Open source Capital Expenditure: 353032 Open source
20172017-12-31	Free cash flow	-28504057	Operating Cash Flow: -27796628 Open source Capital Expenditure: 707429 Open source
20182018-12-31	Free cash flow	-32367671	Operating Cash Flow: -30067255 Open source Capital Expenditure: 2300416 Open source
20192019-12-31	Free cash flow	-48463269	Operating Cash Flow: -45720728 Open source Capital Expenditure: 2742541 Open source
20202020-12-31	Free cash flow	-100170194	Operating Cash Flow: -99685703 Open source Capital Expenditure: 484491 Open source
20212021-12-31	Free cash flow	-48237869	Operating Cash Flow: -48183697 Open source Capital Expenditure: 54172 Open source
20222022-12-31	Free cash flow	-37557884	Operating Cash Flow: -37544435 Open source Capital Expenditure: 13449 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

50.3% 2022

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20152015-12-31	Liabilities / assets	30.2%	Total Liabilities: 3890293 Open source Total Assets: 12875303 Open source
20162016-12-31	Liabilities / assets	50.1%	Total Liabilities: 8968947 Open source Total Assets: 17888182 Open source
20172017-12-31	Liabilities / assets	13.7%	Total Liabilities: 9194600 Open source Total Assets: 66978161 Open source
20182018-12-31	Liabilities / assets	41.4%	Total Liabilities: 19465221 Open source Total Assets: 46989341 Open source
20192019-12-31	Liabilities / assets	87.5%	Total Liabilities: 42984934 Open source Total Assets: 49142499 Open source
20202020-12-31	Liabilities / assets	55.7%	Total Liabilities: 57020006 Open source Total Assets: 102294931 Open source
20212021-12-31	Liabilities / assets	35.9%	Total Liabilities: 38622226 Open source Total Assets: 107730253 Open source
20222022-12-31	Liabilities / assets	50.3%	Total Liabilities: 33321923 Open source Total Assets: 66311940 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

4.76× 2022

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20152015-12-31	Current assets / current liabilities	3.5×	Current Assets: 12714790 Open source Current Liabilities: 3630033 Open source
20162016-12-31	Current assets / current liabilities	1.96×	Current Assets: 17402931 Open source Current Liabilities: 8898591 Open source
20172017-12-31	Current assets / current liabilities	7.98×	Current Assets: 65504730 Open source Current Liabilities: 8204675 Open source
20182018-12-31	Current assets / current liabilities	2.45×	Current Assets: 44240312 Open source Current Liabilities: 18089330 Open source
20192019-12-31	Current assets / current liabilities	1.09×	Current Assets: 38154683 Open source Current Liabilities: 34887706 Open source
20202020-12-31	Current assets / current liabilities	2.89×	Current Assets: 92074631 Open source Current Liabilities: 31897836 Open source
20212021-12-31	Current assets / current liabilities	5.89×	Current Assets: 100204637 Open source Current Liabilities: 17007529 Open source
20222022-12-31	Current assets / current liabilities	4.76×	Current Assets: 60181102 Open source Current Liabilities: 12639938 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2016 2016-01-01 – 2016-12-31	−USD 20 million Exact value Exact value: -19998675 USD 2016-01-01 – 2016-12-31: -19998675 USD Inspect Net Income Open source Share or cite Citation for Net Income · CORBUS PHARMACEUTICALS HOLDINGS, INC. · 2016-12-31 CORBUS PHARMACEUTICALS HOLDINGS, INC. (edgar:1595097) Net Income: -19998675 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T19:45:32Z Snapshot: 36c1ffac13cc9fd73805c6c3dc334e9e5a5281335ba251ab1dfe4499f55c15f0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1595097/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -19998675 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1595097/000149315218003208/crbp-20171231.xml#99350 Filing: 000149315218003208 The citation records this snapshot. The page link may show a newer release later.	−USD 13.57 million Exact value Exact value: -13571227 USD 2016-01-01 – 2016-12-31: -13571227 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CORBUS PHARMACEUTICALS HOLDINGS, INC. · 2016-12-31 CORBUS PHARMACEUTICALS HOLDINGS, INC. (edgar:1595097) Operating Cash Flow: -13571227 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T19:45:32Z Snapshot: 36c1ffac13cc9fd73805c6c3dc334e9e5a5281335ba251ab1dfe4499f55c15f0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1595097/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -13571227 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1595097/000149315218003208/crbp-20171231.xml#419792 Filing: 000149315218003208 The citation records this snapshot. The page link may show a newer release later.	USD 353,032 Exact value Exact value: 353032 USD 2016-01-01 – 2016-12-31: 353032 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CORBUS PHARMACEUTICALS HOLDINGS, INC. · 2016-12-31 CORBUS PHARMACEUTICALS HOLDINGS, INC. (edgar:1595097) Capital Expenditure: 353032 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T19:45:32Z Snapshot: 36c1ffac13cc9fd73805c6c3dc334e9e5a5281335ba251ab1dfe4499f55c15f0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1595097/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 353032 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1595097/000149315218003208/crbp-20171231.xml#419200 Filing: 000149315218003208 The citation records this snapshot. The page link may show a newer release later.	−USD 13.92 million Calculation and evidence -13571227 − 353032 USD Exact free cash flow: -13924259 USD 2016-01-01 – 2016-12-31: -13571227 USD · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 353032 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CORBUS PHARMACEUTICALS HOLDINGS, INC. · 2016-12-31 CORBUS PHARMACEUTICALS HOLDINGS, INC. (edgar:1595097) Free cash flow: -13924259 USD Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T19:45:32Z Snapshot: 36c1ffac13cc9fd73805c6c3dc334e9e5a5281335ba251ab1dfe4499f55c15f0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1595097?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -13571227 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1595097/000149315218003208/crbp-20171231.xml#419792 Filing: 000149315218003208 Input fundies:CapitalExpenditure: 353032 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1595097/000149315218003208/crbp-20171231.xml#419200 Filing: 000149315218003208 The citation records this snapshot. The page link may show a newer release later.
2017 2017-01-01 – 2017-12-31	−USD 32.42 million Exact value Exact value: -32421612 USD 2017-01-01 – 2017-12-31: -32421612 USD Inspect Net Income Open source Share or cite Citation for Net Income · CORBUS PHARMACEUTICALS HOLDINGS, INC. · 2017-12-31 CORBUS PHARMACEUTICALS HOLDINGS, INC. (edgar:1595097) Net Income: -32421612 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T19:45:32Z Snapshot: 36c1ffac13cc9fd73805c6c3dc334e9e5a5281335ba251ab1dfe4499f55c15f0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1595097/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -32421612 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1595097/000149315219003143/crbp-20181231.xml#103774 Filing: 000149315219003143 The citation records this snapshot. The page link may show a newer release later.	−USD 27.8 million Exact value Exact value: -27796628 USD 2017-01-01 – 2017-12-31: -27796628 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CORBUS PHARMACEUTICALS HOLDINGS, INC. · 2017-12-31 CORBUS PHARMACEUTICALS HOLDINGS, INC. (edgar:1595097) Operating Cash Flow: -27796628 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T19:45:32Z Snapshot: 36c1ffac13cc9fd73805c6c3dc334e9e5a5281335ba251ab1dfe4499f55c15f0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1595097/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -27796628 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1595097/000149315219003143/crbp-20181231.xml#365626 Filing: 000149315219003143 The citation records this snapshot. The page link may show a newer release later.	USD 707,429 Exact value Exact value: 707429 USD 2017-01-01 – 2017-12-31: 707429 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CORBUS PHARMACEUTICALS HOLDINGS, INC. · 2017-12-31 CORBUS PHARMACEUTICALS HOLDINGS, INC. (edgar:1595097) Capital Expenditure: 707429 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T19:45:32Z Snapshot: 36c1ffac13cc9fd73805c6c3dc334e9e5a5281335ba251ab1dfe4499f55c15f0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1595097/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 707429 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1595097/000149315219003143/crbp-20181231.xml#327553 Filing: 000149315219003143 The citation records this snapshot. The page link may show a newer release later.	−USD 28.5 million Calculation and evidence -27796628 − 707429 USD Exact free cash flow: -28504057 USD 2017-01-01 – 2017-12-31: -27796628 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 707429 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CORBUS PHARMACEUTICALS HOLDINGS, INC. · 2017-12-31 CORBUS PHARMACEUTICALS HOLDINGS, INC. (edgar:1595097) Free cash flow: -28504057 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T19:45:32Z Snapshot: 36c1ffac13cc9fd73805c6c3dc334e9e5a5281335ba251ab1dfe4499f55c15f0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1595097?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -27796628 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1595097/000149315219003143/crbp-20181231.xml#365626 Filing: 000149315219003143 Input fundies:CapitalExpenditure: 707429 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1595097/000149315219003143/crbp-20181231.xml#327553 Filing: 000149315219003143 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	−USD 55.67 million Exact value Exact value: -55672139 USD 2018-01-01 – 2018-12-31: -55672139 USD Inspect Net Income Open source Share or cite Citation for Net Income · CORBUS PHARMACEUTICALS HOLDINGS, INC. · 2018-12-31 CORBUS PHARMACEUTICALS HOLDINGS, INC. (edgar:1595097) Net Income: -55672139 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T19:45:32Z Snapshot: 36c1ffac13cc9fd73805c6c3dc334e9e5a5281335ba251ab1dfe4499f55c15f0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1595097/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -55672139 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1595097/000149315220004077/crbp-20191231.xml#364998 Filing: 000149315220004077 The citation records this snapshot. The page link may show a newer release later.	−USD 30.07 million Exact value Exact value: -30067255 USD 2018-01-01 – 2018-12-31: -30067255 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CORBUS PHARMACEUTICALS HOLDINGS, INC. · 2018-12-31 CORBUS PHARMACEUTICALS HOLDINGS, INC. (edgar:1595097) Operating Cash Flow: -30067255 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T19:45:32Z Snapshot: 36c1ffac13cc9fd73805c6c3dc334e9e5a5281335ba251ab1dfe4499f55c15f0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1595097/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -30067255 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1595097/000149315220004077/crbp-20191231.xml#277854 Filing: 000149315220004077 The citation records this snapshot. The page link may show a newer release later.	USD 2.3 million Exact value Exact value: 2300416 USD 2018-01-01 – 2018-12-31: 2300416 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CORBUS PHARMACEUTICALS HOLDINGS, INC. · 2018-12-31 CORBUS PHARMACEUTICALS HOLDINGS, INC. (edgar:1595097) Capital Expenditure: 2300416 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T19:45:32Z Snapshot: 36c1ffac13cc9fd73805c6c3dc334e9e5a5281335ba251ab1dfe4499f55c15f0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1595097/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2300416 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1595097/000149315220004077/crbp-20191231.xml#266913 Filing: 000149315220004077 The citation records this snapshot. The page link may show a newer release later.	−USD 32.37 million Calculation and evidence -30067255 − 2300416 USD Exact free cash flow: -32367671 USD 2018-01-01 – 2018-12-31: -30067255 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 2300416 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CORBUS PHARMACEUTICALS HOLDINGS, INC. · 2018-12-31 CORBUS PHARMACEUTICALS HOLDINGS, INC. (edgar:1595097) Free cash flow: -32367671 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T19:45:32Z Snapshot: 36c1ffac13cc9fd73805c6c3dc334e9e5a5281335ba251ab1dfe4499f55c15f0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1595097?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -30067255 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1595097/000149315220004077/crbp-20191231.xml#277854 Filing: 000149315220004077 Input fundies:CapitalExpenditure: 2300416 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1595097/000149315220004077/crbp-20191231.xml#266913 Filing: 000149315220004077 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	−USD 71.45 million Exact value Exact value: -71453718 USD 2019-01-01 – 2019-12-31: -71453718 USD Inspect Net Income Open source Share or cite Citation for Net Income · CORBUS PHARMACEUTICALS HOLDINGS, INC. · 2019-12-31 CORBUS PHARMACEUTICALS HOLDINGS, INC. (edgar:1595097) Net Income: -71453718 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T19:45:32Z Snapshot: 36c1ffac13cc9fd73805c6c3dc334e9e5a5281335ba251ab1dfe4499f55c15f0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1595097/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -71453718 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1595097/000149315221006016/form10-k.htm#1147272 Filing: 000149315221006016 The citation records this snapshot. The page link may show a newer release later.	−USD 45.72 million Exact value Exact value: -45720728 USD 2019-01-01 – 2019-12-31: -45720728 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CORBUS PHARMACEUTICALS HOLDINGS, INC. · 2019-12-31 CORBUS PHARMACEUTICALS HOLDINGS, INC. (edgar:1595097) Operating Cash Flow: -45720728 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T19:45:32Z Snapshot: 36c1ffac13cc9fd73805c6c3dc334e9e5a5281335ba251ab1dfe4499f55c15f0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1595097/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -45720728 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1595097/000149315221006016/form10-k.htm#1045346 Filing: 000149315221006016 The citation records this snapshot. The page link may show a newer release later.	USD 2.74 million Exact value Exact value: 2742541 USD 2019-01-01 – 2019-12-31: 2742541 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CORBUS PHARMACEUTICALS HOLDINGS, INC. · 2019-12-31 CORBUS PHARMACEUTICALS HOLDINGS, INC. (edgar:1595097) Capital Expenditure: 2742541 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T19:45:32Z Snapshot: 36c1ffac13cc9fd73805c6c3dc334e9e5a5281335ba251ab1dfe4499f55c15f0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1595097/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2742541 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1595097/000149315221006016/form10-k.htm#1047047 Filing: 000149315221006016 The citation records this snapshot. The page link may show a newer release later.	−USD 48.46 million Calculation and evidence -45720728 − 2742541 USD Exact free cash flow: -48463269 USD 2019-01-01 – 2019-12-31: -45720728 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 2742541 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CORBUS PHARMACEUTICALS HOLDINGS, INC. · 2019-12-31 CORBUS PHARMACEUTICALS HOLDINGS, INC. (edgar:1595097) Free cash flow: -48463269 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T19:45:32Z Snapshot: 36c1ffac13cc9fd73805c6c3dc334e9e5a5281335ba251ab1dfe4499f55c15f0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1595097?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -45720728 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1595097/000149315221006016/form10-k.htm#1045346 Filing: 000149315221006016 Input fundies:CapitalExpenditure: 2742541 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1595097/000149315221006016/form10-k.htm#1047047 Filing: 000149315221006016 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	−USD 111.27 million Exact value Exact value: -111269380 USD 2020-01-01 – 2020-12-31: -111269380 USD Inspect Net Income Open source Share or cite Citation for Net Income · CORBUS PHARMACEUTICALS HOLDINGS, INC. · 2020-12-31 CORBUS PHARMACEUTICALS HOLDINGS, INC. (edgar:1595097) Net Income: -111269380 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T19:45:32Z Snapshot: 36c1ffac13cc9fd73805c6c3dc334e9e5a5281335ba251ab1dfe4499f55c15f0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1595097/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -111269380 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1595097/000095017022003145/crbp-20211231.htm#1781028 Filing: 000095017022003145 The citation records this snapshot. The page link may show a newer release later.	−USD 99.69 million Exact value Exact value: -99685703 USD 2020-01-01 – 2020-12-31: -99685703 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CORBUS PHARMACEUTICALS HOLDINGS, INC. · 2020-12-31 CORBUS PHARMACEUTICALS HOLDINGS, INC. (edgar:1595097) Operating Cash Flow: -99685703 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T19:45:32Z Snapshot: 36c1ffac13cc9fd73805c6c3dc334e9e5a5281335ba251ab1dfe4499f55c15f0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1595097/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -99685703 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1595097/000095017022003145/crbp-20211231.htm#1558737 Filing: 000095017022003145 The citation records this snapshot. The page link may show a newer release later.	USD 484,491 Exact value Exact value: 484491 USD 2020-01-01 – 2020-12-31: 484491 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CORBUS PHARMACEUTICALS HOLDINGS, INC. · 2020-12-31 CORBUS PHARMACEUTICALS HOLDINGS, INC. (edgar:1595097) Capital Expenditure: 484491 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T19:45:32Z Snapshot: 36c1ffac13cc9fd73805c6c3dc334e9e5a5281335ba251ab1dfe4499f55c15f0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1595097/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 484491 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1595097/000095017022003145/crbp-20211231.htm#1573905 Filing: 000095017022003145 The citation records this snapshot. The page link may show a newer release later.	−USD 100.17 million Calculation and evidence -99685703 − 484491 USD Exact free cash flow: -100170194 USD 2020-01-01 – 2020-12-31: -99685703 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 484491 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CORBUS PHARMACEUTICALS HOLDINGS, INC. · 2020-12-31 CORBUS PHARMACEUTICALS HOLDINGS, INC. (edgar:1595097) Free cash flow: -100170194 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T19:45:32Z Snapshot: 36c1ffac13cc9fd73805c6c3dc334e9e5a5281335ba251ab1dfe4499f55c15f0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1595097?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -99685703 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1595097/000095017022003145/crbp-20211231.htm#1558737 Filing: 000095017022003145 Input fundies:CapitalExpenditure: 484491 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1595097/000095017022003145/crbp-20211231.htm#1573905 Filing: 000095017022003145 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 45.64 million Exact value Exact value: -45640426 USD 2021-01-01 – 2021-12-31: -45640426 USD Inspect Net Income Open source Share or cite Citation for Net Income · CORBUS PHARMACEUTICALS HOLDINGS, INC. · 2021-12-31 CORBUS PHARMACEUTICALS HOLDINGS, INC. (edgar:1595097) Net Income: -45640426 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T19:45:32Z Snapshot: 36c1ffac13cc9fd73805c6c3dc334e9e5a5281335ba251ab1dfe4499f55c15f0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1595097/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -45640426 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1595097/000095017023006469/crbp-20221231.htm#2563724 Filing: 000095017023006469 The citation records this snapshot. The page link may show a newer release later.	−USD 48.18 million Exact value Exact value: -48183697 USD 2021-01-01 – 2021-12-31: -48183697 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CORBUS PHARMACEUTICALS HOLDINGS, INC. · 2021-12-31 CORBUS PHARMACEUTICALS HOLDINGS, INC. (edgar:1595097) Operating Cash Flow: -48183697 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T19:45:32Z Snapshot: 36c1ffac13cc9fd73805c6c3dc334e9e5a5281335ba251ab1dfe4499f55c15f0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1595097/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -48183697 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1595097/000095017023006469/crbp-20221231.htm#1701961 Filing: 000095017023006469 The citation records this snapshot. The page link may show a newer release later.	USD 54,172 Exact value Exact value: 54172 USD 2021-01-01 – 2021-12-31: 54172 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CORBUS PHARMACEUTICALS HOLDINGS, INC. · 2021-12-31 CORBUS PHARMACEUTICALS HOLDINGS, INC. (edgar:1595097) Capital Expenditure: 54172 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T19:45:32Z Snapshot: 36c1ffac13cc9fd73805c6c3dc334e9e5a5281335ba251ab1dfe4499f55c15f0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1595097/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 54172 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1595097/000095017023006469/crbp-20221231.htm#1719205 Filing: 000095017023006469 The citation records this snapshot. The page link may show a newer release later.	−USD 48.24 million Calculation and evidence -48183697 − 54172 USD Exact free cash flow: -48237869 USD 2021-01-01 – 2021-12-31: -48183697 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 54172 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CORBUS PHARMACEUTICALS HOLDINGS, INC. · 2021-12-31 CORBUS PHARMACEUTICALS HOLDINGS, INC. (edgar:1595097) Free cash flow: -48237869 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T19:45:32Z Snapshot: 36c1ffac13cc9fd73805c6c3dc334e9e5a5281335ba251ab1dfe4499f55c15f0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1595097?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -48183697 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1595097/000095017023006469/crbp-20221231.htm#1701961 Filing: 000095017023006469 Input fundies:CapitalExpenditure: 54172 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1595097/000095017023006469/crbp-20221231.htm#1719205 Filing: 000095017023006469 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 42.35 million Exact value Exact value: -42346903 USD 2022-01-01 – 2022-12-31: -42346903 USD Inspect Net Income Open source Share or cite Citation for Net Income · CORBUS PHARMACEUTICALS HOLDINGS, INC. · 2022-12-31 CORBUS PHARMACEUTICALS HOLDINGS, INC. (edgar:1595097) Net Income: -42346903 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T19:45:32Z Snapshot: 36c1ffac13cc9fd73805c6c3dc334e9e5a5281335ba251ab1dfe4499f55c15f0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1595097/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -42346903 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1595097/000095017024030133/crbp-20231231.htm#2229915 Filing: 000095017024030133 The citation records this snapshot. The page link may show a newer release later.	−USD 37.54 million Exact value Exact value: -37544435 USD 2022-01-01 – 2022-12-31: -37544435 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CORBUS PHARMACEUTICALS HOLDINGS, INC. · 2022-12-31 CORBUS PHARMACEUTICALS HOLDINGS, INC. (edgar:1595097) Operating Cash Flow: -37544435 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T19:45:32Z Snapshot: 36c1ffac13cc9fd73805c6c3dc334e9e5a5281335ba251ab1dfe4499f55c15f0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1595097/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -37544435 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1595097/000095017024030133/crbp-20231231.htm#1685594 Filing: 000095017024030133 The citation records this snapshot. The page link may show a newer release later.	USD 13,449 Exact value Exact value: 13449 USD 2022-01-01 – 2022-12-31: 13449 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CORBUS PHARMACEUTICALS HOLDINGS, INC. · 2022-12-31 CORBUS PHARMACEUTICALS HOLDINGS, INC. (edgar:1595097) Capital Expenditure: 13449 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T19:45:32Z Snapshot: 36c1ffac13cc9fd73805c6c3dc334e9e5a5281335ba251ab1dfe4499f55c15f0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1595097/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 13449 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1595097/000095017024030133/crbp-20231231.htm#1696046 Filing: 000095017024030133 The citation records this snapshot. The page link may show a newer release later.	−USD 37.56 million Calculation and evidence -37544435 − 13449 USD Exact free cash flow: -37557884 USD 2022-01-01 – 2022-12-31: -37544435 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 13449 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CORBUS PHARMACEUTICALS HOLDINGS, INC. · 2022-12-31 CORBUS PHARMACEUTICALS HOLDINGS, INC. (edgar:1595097) Free cash flow: -37557884 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T19:45:32Z Snapshot: 36c1ffac13cc9fd73805c6c3dc334e9e5a5281335ba251ab1dfe4499f55c15f0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1595097?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -37544435 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1595097/000095017024030133/crbp-20231231.htm#1685594 Filing: 000095017024030133 Input fundies:CapitalExpenditure: 13449 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1595097/000095017024030133/crbp-20231231.htm#1696046 Filing: 000095017024030133 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−USD 44.6 million Exact value Exact value: -44604000 USD 2023-01-01 – 2023-12-31: -44604000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CORBUS PHARMACEUTICALS HOLDINGS, INC. · 2023-12-31 CORBUS PHARMACEUTICALS HOLDINGS, INC. (edgar:1595097) Net Income: -44604000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T19:45:32Z Snapshot: 36c1ffac13cc9fd73805c6c3dc334e9e5a5281335ba251ab1dfe4499f55c15f0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1595097/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -44604000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1595097/000095017025037335/crbp-20241231.htm#2673990 Filing: 000095017025037335 The citation records this snapshot. The page link may show a newer release later.	−USD 36.1 million Exact value Exact value: -36100000 USD 2023-01-01 – 2023-12-31: -36100000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CORBUS PHARMACEUTICALS HOLDINGS, INC. · 2023-12-31 CORBUS PHARMACEUTICALS HOLDINGS, INC. (edgar:1595097) Operating Cash Flow: -36100000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T19:45:32Z Snapshot: 36c1ffac13cc9fd73805c6c3dc334e9e5a5281335ba251ab1dfe4499f55c15f0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1595097/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -36100000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1595097/000095017025037335/crbp-20241231.htm#2076155 Filing: 000095017025037335 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2023-01-01 – 2023-12-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CORBUS PHARMACEUTICALS HOLDINGS, INC. · 2023-12-31 CORBUS PHARMACEUTICALS HOLDINGS, INC. (edgar:1595097) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T19:45:32Z Snapshot: 36c1ffac13cc9fd73805c6c3dc334e9e5a5281335ba251ab1dfe4499f55c15f0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1595097/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1595097/000095017024030133/crbp-20231231.htm#1694774 Filing: 000095017024030133 The citation records this snapshot. The page link may show a newer release later.	−USD 36.1 million Calculation and evidence -36100000 − 0 USD Exact free cash flow: -36100000 USD 2023-01-01 – 2023-12-31: -36100000 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CORBUS PHARMACEUTICALS HOLDINGS, INC. · 2023-12-31 CORBUS PHARMACEUTICALS HOLDINGS, INC. (edgar:1595097) Free cash flow: -36100000 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T19:45:32Z Snapshot: 36c1ffac13cc9fd73805c6c3dc334e9e5a5281335ba251ab1dfe4499f55c15f0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1595097?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -36100000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1595097/000095017025037335/crbp-20241231.htm#2076155 Filing: 000095017025037335 Input fundies:CapitalExpenditure: 0 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1595097/000095017024030133/crbp-20231231.htm#1694774 Filing: 000095017024030133 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	−USD 40.21 million Exact value Exact value: -40209000 USD 2024-01-01 – 2024-12-31: -40209000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CORBUS PHARMACEUTICALS HOLDINGS, INC. · 2024-12-31 CORBUS PHARMACEUTICALS HOLDINGS, INC. (edgar:1595097) Net Income: -40209000 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T19:45:32Z Snapshot: 36c1ffac13cc9fd73805c6c3dc334e9e5a5281335ba251ab1dfe4499f55c15f0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1595097/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: -40209000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1595097/000119312526098530/crbp-20251231.htm#2889498 Filing: 000119312526098530 The citation records this snapshot. The page link may show a newer release later.	−USD 41.79 million Exact value Exact value: -41794000 USD 2024-01-01 – 2024-12-31: -41794000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CORBUS PHARMACEUTICALS HOLDINGS, INC. · 2024-12-31 CORBUS PHARMACEUTICALS HOLDINGS, INC. (edgar:1595097) Operating Cash Flow: -41794000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T19:45:32Z Snapshot: 36c1ffac13cc9fd73805c6c3dc334e9e5a5281335ba251ab1dfe4499f55c15f0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1595097/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -41794000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1595097/000119312526098530/crbp-20251231.htm#2242196 Filing: 000119312526098530 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2024-01-01 – 2024-12-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CORBUS PHARMACEUTICALS HOLDINGS, INC. · 2024-12-31 CORBUS PHARMACEUTICALS HOLDINGS, INC. (edgar:1595097) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T19:45:32Z Snapshot: 36c1ffac13cc9fd73805c6c3dc334e9e5a5281335ba251ab1dfe4499f55c15f0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1595097/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1595097/000119312526098530/crbp-20251231.htm#2248546 Filing: 000119312526098530 The citation records this snapshot. The page link may show a newer release later.	−USD 41.79 million Calculation and evidence -41794000 − 0 USD Exact free cash flow: -41794000 USD 2024-01-01 – 2024-12-31: -41794000 USD · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CORBUS PHARMACEUTICALS HOLDINGS, INC. · 2024-12-31 CORBUS PHARMACEUTICALS HOLDINGS, INC. (edgar:1595097) Free cash flow: -41794000 USD Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T19:45:32Z Snapshot: 36c1ffac13cc9fd73805c6c3dc334e9e5a5281335ba251ab1dfe4499f55c15f0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1595097?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -41794000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1595097/000119312526098530/crbp-20251231.htm#2242196 Filing: 000119312526098530 Input fundies:CapitalExpenditure: 0 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1595097/000119312526098530/crbp-20251231.htm#2248546 Filing: 000119312526098530 The citation records this snapshot. The page link may show a newer release later.
2025 2025-01-01 – 2025-12-31	−USD 78.54 million Exact value Exact value: -78537000 USD 2025-01-01 – 2025-12-31: -78537000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CORBUS PHARMACEUTICALS HOLDINGS, INC. · 2025-12-31 CORBUS PHARMACEUTICALS HOLDINGS, INC. (edgar:1595097) Net Income: -78537000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T19:45:32Z Snapshot: 36c1ffac13cc9fd73805c6c3dc334e9e5a5281335ba251ab1dfe4499f55c15f0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1595097/explain?concept=fundies%3ANetIncome&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:NetIncome: -78537000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1595097/000119312526098530/crbp-20251231.htm#2887641 Filing: 000119312526098530 The citation records this snapshot. The page link may show a newer release later.	−USD 64.49 million Exact value Exact value: -64491000 USD 2025-01-01 – 2025-12-31: -64491000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CORBUS PHARMACEUTICALS HOLDINGS, INC. · 2025-12-31 CORBUS PHARMACEUTICALS HOLDINGS, INC. (edgar:1595097) Operating Cash Flow: -64491000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T19:45:32Z Snapshot: 36c1ffac13cc9fd73805c6c3dc334e9e5a5281335ba251ab1dfe4499f55c15f0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1595097/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -64491000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1595097/000119312526098530/crbp-20251231.htm#2240341 Filing: 000119312526098530 The citation records this snapshot. The page link may show a newer release later.	USD 7,000 Exact value Exact value: 7000 USD 2025-01-01 – 2025-12-31: 7000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CORBUS PHARMACEUTICALS HOLDINGS, INC. · 2025-12-31 CORBUS PHARMACEUTICALS HOLDINGS, INC. (edgar:1595097) Capital Expenditure: 7000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T19:45:32Z Snapshot: 36c1ffac13cc9fd73805c6c3dc334e9e5a5281335ba251ab1dfe4499f55c15f0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1595097/explain?concept=fundies%3ACapitalExpenditure&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 7000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1595097/000119312526098530/crbp-20251231.htm#2246907 Filing: 000119312526098530 The citation records this snapshot. The page link may show a newer release later.	−USD 64.5 million Calculation and evidence -64491000 − 7000 USD Exact free cash flow: -64498000 USD 2025-01-01 – 2025-12-31: -64491000 USD · Inspect Operating Cash Flow · Source 2025-01-01 – 2025-12-31: 7000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CORBUS PHARMACEUTICALS HOLDINGS, INC. · 2025-12-31 CORBUS PHARMACEUTICALS HOLDINGS, INC. (edgar:1595097) Free cash flow: -64498000 USD Concept: free-cash-flow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T19:45:32Z Snapshot: 36c1ffac13cc9fd73805c6c3dc334e9e5a5281335ba251ab1dfe4499f55c15f0 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1595097?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -64491000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1595097/000119312526098530/crbp-20251231.htm#2240341 Filing: 000119312526098530 Input fundies:CapitalExpenditure: 7000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1595097/000119312526098530/crbp-20251231.htm#2246907 Filing: 000119312526098530 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

112 filings · 3,019 latest values · 3,019 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001595097, 1595097, CRBP, edgar:1595097

Also known as CORBUS PHARMACEUTICALS HOLDINGS, INC., Corbus Pharmaceuticals Holdings, Inc., SAV Acquisition Corp

CORBUS PHARMACEUTICALS HOLDINGS, INC.

Latest quarter

Revenue

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Net income

Operating cash flow

Company performance

What changed year over year

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2022 2022-01-01 – 2022-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation